Home › Funds › ACT Capital Partners, L.P. › CADL
ACT Capital Partners, L.P. position in CADL
CANDEL THERAPEUTICS INC · Health Care
ACT Capital Partners, L.P. reported holding 150,500 shares of CADL (CANDEL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 1.07% of its reported portfolio and ranking #23 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s CADL position evolved
ACT Capital Partners, L.P. first disclosed a stake in CADL in Q3 2026 at 150,500 shares (US$1.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 150.50K | $1.57M | New |
About CADL and 13F data
CADL (CANDEL THERAPEUTICS INC) is a Health Care company. 83 other funds we track also report a position in CADL — the largest reported positions include RTW INVESTMENTS, LP (US$66.1M), ACORN CAPITAL ADVISORS, LLC (US$36.0M), Portolan Capital Management, LLC (US$36.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CADL
- RTW INVESTMENTS, LP 6.42M sh · $66.15M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 3.50M sh · $36.03M · Q2 2026
- Portolan Capital Management, LLC 3.49M sh · $35.95M · Q2 2026
- Saturn V Capital Management LP 3.30M sh · $34.03M · Q2 2026
- Sands Capital Alternatives, LLC 405.84K sh · $4.18M · Q2 2026
- Tanager Wealth Management LLP 198.18K sh · $2.07M · Q3 2026
- Kynam Capital Management, LP 96.74K sh · $996.43K · Q2 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held CADL?
ACT Capital Partners, L.P. has disclosed CADL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in CADL?
As of Q3 2026, ACT Capital Partners, L.P. holds 150.50K shares of CADL (CANDEL THERAPEUTICS INC), valued at $1.57M, representing 1.07% of its reported portfolio and ranking #23.
Has ACT Capital Partners, L.P. been buying or selling CADL?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in CADL.
Which other funds hold CADL?
Other major institutional holders of CADL include RTW INVESTMENTS, LP, ACORN CAPITAL ADVISORS, LLC, Portolan Capital Management, LLC, among 83 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.